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Abstract: The zoonotic human pathogen Campylobacter jejuni is known for its ability to induce
DNA-damage and cell death pathology in humans. The molecular mechanism behind this
phenomenon involves nuclear translocation by Cas9, a nuclease in C. jejuni (CjeCas9) that is the
molecular marker of the Type II CRISPR-Cas system. However, it is unknown via which cellular
pathways CjeCas9 drives human intestinal epithelial cells into cell death. Here, we show that
CjeCas9 released by C. jejuni during the infection of Caco-2 human intestinal epithelial cells directly
modulates Caco-2 transcriptomes during the first four hours of infection. Specifically, our results
reveal that CjeCas9 activates DNA damage (p53, ATM (Ataxia Telangiectasia Mutated Protein)),
pro-inflammatory (NF-κB (Nuclear factor-κB)) signaling and cell death pathways, driving Caco-2 cells
infected by wild-type C. jejuni, but not when infected by a cas9 deletion mutant, towards programmed
cell death. This work corroborates our previous finding that CjeCas9 is cytotoxic and highlights on a
RNA level the basal cellular pathways that are modulated.
Keywords: Campylobacter jejuni; Cas9; Caco-2; cell death; p53; NF-κB
1. Introduction
Campylobacter jejuni is a zoonotic bacterial pathogen that causes gastrointestinal infections,
with symptoms including (bloody) diarrhea or dysentery-like conditions such as cramps, fever and
pain [1], also known as Campylobacteriosis. Clinical manifestations of C. jejuni infections are the
consequences of the ability of pathogenic C. jejuni bacteria to disrupt the intestinal epithelial barrier [2,3],
concomitant with DNA damage and intestinal epithelial cell death [4,5]. In this process, there are
important roles for virulence factors that mediate adhesion onto, invasion into and translocation across
intestinal epithelial cells, and bacterial motility [6–10]. In vitro, we and others have shown that C.
jejuni adheres onto and invades into intestinal epithelial cells in a two to four hour time window,
in which sialylated lipo-oligosaccharides (LOS), enterotoxins, cytotoxins, adhesins and motile flagella
play important roles [5–12]. Upon epithelial cell infection, C. jejuni co-localizes with cellular endosomal
markers at specific time points [13,14]. This 2–4 h process is a crucial time period, since it determines if
C. jejuni are killed in the phagolysosome or if bacteria survive and translocate across the intestinal
epithelial barrier [12,13].
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To infect and damage host cells, some bacteria target host DNA [15]. In C. jejuni,
Cytolethal Distending Toxin (CDT) can damage host DNA [15–18], but isolates lacking CDT still
induce DNA damage, cell death [4] and campylobacteriosis [19,20], indicating that additional virulence
factors contribute to host DNA damage. We revealed that the protein encoded by Clustered Regularly
Interspaced Palindromic Repeat and associated gene 9 (cas9) of C. jejuni (CjeCas9) is necessary to induce
DNA damage and cell death during the infection process in a variety of cell lines [14]. In C. jejuni-infected
cells, the DNA damage markers 53BP1 and y-H2AX are massively activated and contribute to the repair
of CjeCas9 related DNA damage [14]. Others have shown that C. jejuni can translocate across human
intestinal epithelial barrier in the presence of CjeCas9 [21], and that translocation is accompanied with
a significant drop in the transepithelial electrical resistance (TER) [12,22]. The most parsimonious
explanation for these findings is that CjeCas9 might directly induce cytotoxicity via one or multiple
processes. In order to pinpoint these processes, we carried out infection assays with Caco-2 intestinal
epithelial cells using a wild-type strain and a corresponding isogenic cas9 deletion mutant [21] and
monitored the infection process by extracting total RNA at biologically relevant time points that we
earlier determined [11,12] for whole-genome transcriptomics. We intended to validate our hypothesis
that CjeCas9 activates the DNA damage and cell fate pathways [14,21].
2. Materials and Methods
2.1. Bacterial Strains and Growth Conditions
Campylobacter jejuni strain NCTC11168 with a complete CRISPR-Cas system is used in this
study [12,21,23]. The methods for generating a ∆cas9 mutant strain have been described previously [12,
21]. C. jejuni was cultured on blood agar plates, containing 7% sheep blood (Becton Dickinson,
Breda, the Netherlands) supplemented with vancomycin (10 µg/mL). The isogenic ∆cas9 mutant,
generated in the NCTC11168 background, was cultured using the above medium supplemented with
chloramphenicol (20 µg/mL) (Sigma-Aldrich, Zwijndrecht, the Netherlands). C. jejuni was cultured
under micro-aerophilic conditions at 37 ◦C, using anaerobic jars and an Anoxomat (Mart Microbiology
B.V., Drachten, the Netherlands).
2.2. Eukaryotic Cell Maintenance
The human intestinal epithelial cell line Caco-2 (human epithelial colorectal adenocarcinoma cells)
was maintained in Dulbecco’s modified Eagle’s medium (DMEM) (Thermo Fisher Scientific, Bleiswijk,
the Netherlands) supplemented with 10% fetal bovine serum (FBS) (Thermo Fisher Scientific, Bleiswijk,
the Netherlands), 100 U/mL penicillin, 100 µg/mL streptomycin and 1% non-essential amino acids
(NEAAs) (Thermo Fisher Scientific, Bleiswijk, the Netherlands). The Caco-2 cells were cultured in
a 75-cm2 flask (Greiner Bio-one, Alphen aan den Rijn, the Netherlands) at 37 ◦C and 5% CO2 in a
humidified air incubator.
2.3. Transwell Cellular Assay
Transwell filters (Costar, Corning Inc., Corning, New York, NY, USA) were coated with collagen
(50 µg/mL in 0.02 M acetic acid). Caco-2 cells were seeded at the apical surface of coated Transwell
filters at a density of 4.0 × 105 cells/filter (5-µm pore size, 1.13 cm2; (Costar) in 400 µL DMEM medium
(Thermo fisher scientific) + Glutamax (Thermo fisher Scientific, Bleiswijk, the Netherlands) with 10%
FBS (Thermo fisher Scientific), 1% glutamine (Thermo fisher Scientific, Bleiswijk, the Netherlands) and
1× Penicillin/Streptomycin (Thermo fisher Scientific). Nine hundred microliter of the above medium
was added to the basolateral surface and 400 microliter was added to the apical surface of the Caco-2
cells, which were allowed to differentiate for 19–21 days with medium replacements every other day
accompanied with transepithelial electrical resistance (TER) measurements. Plates were incubated at
37 ◦C in 5% CO2 in a humidified incubator (Binder, Tuttlingen, Germany). TER above >1000 Ω/cm2
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indicated that intact epithelial monolayers were present, usually at day 19 [12] and can be used as a
model for the human epithelial barrier [24].
When carrying out infection assays, the medium described above was replaced with the same
medium, but lacking antibiotics. Bacterial strains were added at a multiplicity of infection (MOI)
of 10 to the apical surface of the Caco-2 cells at day 19–21. After 48 h, Transwells (Costar) were
rinsed with phosphate-buffered saline (PBS) (Thermo Fisher Scientific, Bleiswijk, the Netherlands) at
37 ◦C and fixed with 4% paraformaldehyde (Sigma-Aldrich, Zwijndrecht, the Netherlands) for one
hour. Transwells were washed in PBS and dehydrated in 70% ethanol (Sigma-Aldrich, Zwijndrecht,
the Netherlands) (2× 15 min), 96% ethanol (2× 20 min), 100% ethanol (1× 10 min and 2× 20 min) and 100%
butanol (Sigma-Aldrich, Zwijndrecht, the Netherlands) (1× 20 min and 2× 30 min). Membranes were
embedded in paraffin (Sigma-Aldrich, Zwijndrecht, the Netherlands) and stored at room temperature
until sectioned. Then, 5-µM-thick slides were deparaffinated in xylene (Sigma-Aldrich, Zwijndrecht,
the Netherlands), dehydrated in a graded ethanol series (100%, 96%, 90%, 80%, 70%, 50%) and
finally rinsed in H2O. Transwell sections were stained with Hematoxylin (Sigma-Aldrich, Zwijndrecht,
the Netherlands) and Eosin (HE staining) (Sigma-Aldrich, Zwijndrecht, the Netherlands) and analyzed
using the microscope at 40×magnification using bright-field illumination.
2.4. RNA and Microarray Handling for Transcriptomics of C. jejuni Infected Human Cells
To investigate genome-wide transcriptional responses of Caco-2 intestinal epithelial cells to
infection with C. jejuni, Caco-2 cells were seeded in 6-well plates (Greiner Bio-One) at a density of
1.0 x 105 cells per well, grown to confluence and allowed to differentiate for 19 days and infected.
Three biological replicates (3 different wells) were used per wild-type (WT) and its isogenic ∆cas9
mutant per time point. At the t = 0 hr time point, cells were incubated with bacteria or medium only
(mock infection challenge). Five additional time points of RNA extraction—30, 60, 120, 180, and 240
min—after infection were rationally chosen based on our earlier work [12]. At each time point, 1
mL of TRIzol® reagent (Ambion Life Technologies) was added to the appropriate wells and total
RNA was extracted from the Caco-2 cells following the manufacturer’s protocol. Air-dried RNA
was re-suspended in 100 µL MilliQ water and purified and desalted using Qiagen RNeasy Mini Kit
spin columns following the manufacturer’s instructions. RNA quantity and quality was assessed
spectrophotometrically via a Nanodrop device (ND-1000, NanoDrop Technologies, Wilmington, DE,
USA) and with 6000 Nano chips via a Bioanalyzer 2100 device (Agilent, Santa Clara, CA, USA),
respectively. RNA was judged as being suitable for array hybridization only if samples showed intact
bands corresponding to the 18S and 28S ribosomal RNA subunits, displayed no chromosomal peaks
or RNA degradation products, and had a RIN (RNA integrity number) above 8.0. The Ambion WT
Expression kit (Life Technologies, cat. no. 4411974) in conjunction with the Affymetrix GeneChip WT
Terminal Labelling kit (Affymetrix, Santa Clara, CA, USA; cat. no. 900671) was used for the preparation
of labelled cDNA from 100 ng of total RNA without rRNA reduction. Labelled samples were hybridized
on Affymetrix GeneChip Human Gene 1.1 ST arrays that contain 30,000 coding transcripts and over
11,000 long intergenic non-coding transcripts, provided in plate format. The hybridization, washing and
scanning of the array plates were performed on an Affymetrix GeneTitan Instrument, according to the
manufacturer’s recommendations. Detailed protocols can be found in the Affymetrix WT Terminal
Labelling and Hybridization User Manual (part no. 702808 revision 4), and are also available upon
request. Quality control of the hybridizations to the Human Gene 1.1 ST array and primary data
analysis were performed according to strict criteria to ensure that the array data were of the highest
possible quality (below).
2.5. Statistical and Functional Analysis of Microarray Data
Packages from the Bioconductor project [25] were used for analyzing scanned Affymetrix
transcriptome arrays. Arrays were normalized using quantile normalization, and expression estimates
were compiled using the pre-processing algorithm Robust Multi-array Analysis (RMA), applying the
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empirical Bayes approach available in the Bioconductor library affyPLM using default settings.
Gene functional annotations, gene ontology (GO) enrichment and differential expression calculations
were carried out using Bioconductor [25] packages and third-party software modules (see below).
The Bioconductor packages were integrated in the automated on-line MADMAX pipeline [26].
Various advanced quality metrics, diagnostic plots, pseudo-images and classification methods were
applied to ascertain that only arrays that passed the most rigorous quality controls were used in
the subsequent analyses [27]. Arrays were considered of sufficient quality when they showed no
more than 10% of specks in fitPLM model images, were not deviating in RNA degradation and
density plots, when they were not significantly deviating in Normalized Unscaled Standard Error
(NUSE) and Relative log expression (RLE) plots and were within each other’s range in boxplots. For a
more extensive description of quality criteria, please contact the authors. Probe sets were redefined
according to Dai et al. [28] utilizing current genome information. In this study, probes were reorganized
based on the NCBI (National Center for Biotechnology Information) Entrez Gene database (remapped
CDF v15, http://brainarray.mbni.med.umich.edu). Differentially expressed probe sets were identified
using linear models, applying moderated t-statistics that implement empirical Bayes regularization of
standard errors using Bioconductor’s limma package [29]. A Bayesian hierarchical model was used
to define an intensity-based moderated T-statistic (IBMT), which takes into account the degree of
independence of variances relative to the degree of identity and the relationship between variance
and signal intensity [30]. When gene expression was low and just below significance, results of the
limma test were compared to the IBMT test. p-values were corrected for multiple testing using a false
discovery rate (FDR) method [31]; the quality of the data was such that FDR p-values (Q values) of
<0.01 to <0.0001 yielded hundreds of, to several thousand, differentials, depending on the time point
and C. jejuni strain. For pathway analysis comparisons, it is difficult to use different numbers of input
genes (several hundred compared to several thousand), which would occur if a fixed FDR p-value was
used for all datasets submitted to pathway analysis. Therefore, FDR values between p < 0.01 and p <
0.0001 were chosen such that the number of genes included in Ingenuity Pathway Analysis (IPA) and
Cytoscape [32] were in the range of 700–1000 genes.
2.6. Biological Interpretation of Transcriptome Datasets
Time-resolved differential gene expression data were obtained using Short Time-series Expression
Miner (STEM) software [33]. To identify pathways and processes among regulated genes activated in
response to infection by NCTC11168 or its isogenic ∆cas9 mutant at each time point, Ingenuity Pathways
Analysis (IPA) (Ingenuity Systems, Redwood City, CA, USA) was used (below). For network analysis,
the same infection response datasets were imported into Cytoscape [32] and interactions of the proteins
encoded by the differentials were obtained via the Bisogenet plugin. The output was used to prioritize
differentially regulated pathways that reflect Caco-2 responses to bacterial infection, to identify cascades
of upstream transcriptional regulators that could explain the observed gene expression changes, and to
reconstruct protein–protein networks that could be used to overlay gene expression data and identify
central regulatory proteins that were most likely to have driven differential gene expression following
infection by C. jejuni. We used three complementary methods for functional analysis of microarray
expression data: ErmineJ (GO annotation enrichment or overrepresentation), gene set enrichment
analysis and IPA (see below). Using these, we performed: (i) identification of statistically supported
overrepresentation of functional gene ontology (GO) annotation, (ii) mapping of expression data onto
pathways to determine their up- or downregulation in a statistical meaningful way (IPA), (iii) projection
of transcript fold-change values of co-expressed genes onto interaction maps of the corresponding
proteins (IPA and Cytoscape), and (iv) the reconstruction of networks from the interactions of proteins
expressed by all gene differentials per dataset to identify central regulators. Two complementary
methods were applied to relate changes in gene expression to functional changes. One method, ErmineJ,
is based on the overrepresentation of Gene Ontology (GO) terms [34]. As input all t-test p-values from
the probe set comparisons across the respective conditions were used. Another approach, gene set
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enrichment analysis (GSEA) takes into account the broader context in which gene products function,
namely in physically interacting networks, such as biochemical, metabolic or signal transduction
routes [35]. This method aids the identification of up- or downregulated processes. Due to overlap in
the source databases, cellular functions may be represented multiple times. Both applied methods
have the advantage that they are unbiased, because no gene selection step is used, and a score is
computed based on all genes in a particular GO term or gene set. To evaluate the statistical support for
similarity of expression datasets as calculated by GSEA, we made use of the three p-values provided
by the GSEA algorithm. Statistical support was considered sufficiently convincing when meeting the
following criteria: nominal p-values < 0.05, FDR p-values < 0.2, and FWER values < 0.25. In practice,
GSEA conclusions were based on p-values closely approaching 0.
2.7. Pathway Analysis
All listed or reconstructed cellular pathways were derived from the expert-annotated pathways that
are provided by the Kyoto Encyclopedia of Genes and Genomes (KEGG www.genome.jp/kegg) and the
Ingenuity Knowledge Base (www.ingenuity.com) or were reconstructed from known protein–protein
and protein–DNA interaction information that is present in on-line databases including those from
NCBI, Ensembl, BIND (Biomolecular Interaction Network Database), KEGG and MIPS (Munich
Information Center for Protein Sequences). Furthermore, the localization and expression of the
proteins that were encoded by differentially expressed genes were cross-checked in the Human Protein
Resource Database (www.hprd.org). This resource not only provides information on tissue-specific
expression of human proteins, but also includes histological images showing cell-specific expression
for many of the proteins discussed in this manuscript. As a consequence, the data interpretation
was exclusively built on existing and curated information, and all interpretations were based on
validated information. Biological cellular functions and transcriptional networks altered after the
consumption of bacterial preparations were identified using IPA; Ingenuity Systems, Redwood City,
CA. IPA annotations follow the GO annotation principle, but are based on a proprietary knowledge
base of over 1,000,000 protein–protein interactions. For IPA analysis, gene expression ratios x between
0 and 1 were transformed to negative fold-changes using the formula fc = −1/(ratio x). We also
performed an IPA upstream regulator analysis to identify the cascade of upstream transcriptional
regulators that can explain the observed gene expression changes in a user’s dataset, which can
provide insights into the biological activities occurring in the tissues or cells being studied. The IPA
output includes metabolic and signaling pathways with statistical assessment of the significance of
their representation being based on Fisher’s Exact Test. This test calculates the probability that genes
participate in a given pathway relative to their occurrence in all other pathway annotations. Input gene
lists included the differentially regulated genes (FDR p-values (Q values) < 0.001 or <0.0001 where
appropriate; we aimed to include 700–1000 genes for IPA analysis, since the statistical output of the
Fisher’s Exact Test that IPA uses is sensitive to highly diverse numbers of input genes. IPA computes
networks and ranks these according to a statistical likelihood approach. All networks with a score
of at least 10 focus genes were considered to be biologically relevant and representative to show
part of the underlying biology of the responses of Caco-2 cells to infection challenges by WT or its
isogenic ∆cas9 mutant. Every interaction between gene products in the network was supported by
published information that was directly retrieved from within the Ingenuity knowledge base. In order
to identify major activated networks and pathways, a fold-change cut-off value of two was used.
In order to reconstruct cellular pathways including those genes that showed significantly altered
expression, a fold-change cut-off of 1.1 was used. Small (10–40%) changes in gene expression in
human tissue induced by mild stimuli have been published earlier [36] and may be a characteristic of
mean expression changes in human tissue, typically containing cellular regions with possibly differing
gene expression programs. Common (canonical) pathway results obtained using software suites such
as IPA are partially determined by the content of the supporting databases, the “knowledge base”.
To further evaluate the IPA results, we used a second type of in silico pathway analysis, delivered by
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the Cytoscape platform that uses all main publicly available databases including STRING, NCBI,
Uniprot and KEGG, in contrast to Qiagen IPA, which is based on a proprietary manually curated
data of human, mouse and rat protein–protein, protein–DNA and protein–compound interactions.
To access these public databases, the Bisogenet, PSICQUICUniversalClient and StringWSClient plugins
were used to construct protein–protein interaction networks representing the proteins encoded by the
differentially expressed genes. Major nodes, candidate regulators of the Caco-2 response to infection
with WT or isogenic ∆cas9 mutant bacteria, were identified using the cytoHubba plugin. All plugins
and the documentation describing them can be retrieved via http://apps.cytoscape.org.
3. Results
3.1. CjeCas9 Triggers Caco-2 Cell Damage
CjeCas9 is required for the efficient C. jejuni infection of human cells including cell death
induction [21,37]. To investigate the contribution of CjeCas9 to the induction of host damage and
death, we used the NCTC11168 (WT) strain and its isogenic ∆cas9 mutant (Figure 1a) in epithelial cell
(Caco-2) infection assays. Challenges with the wild-type CjeCas9-producing strain resulted in the
induction of swelling of differentiated human intestinal epithelial Caco-2 cells, indicated by arrows
in the upper panel of (Figure 1b). Such cell swelling was not observed when these Caco-2 cells were
exposed to the isogenic ∆cas9 mutant (Figure 1b).
Figure 1. CjeCas9 induces cell damage. (a) Organization of the C. jejuni CRISPR-Cas locus in the
wild-type NCTC11168 (WT) strain and its isogenic cas9 deletion mutant (∆cas9). Transcriptional
direction of the cas genes are indicated [38]; (b) Transwell sections showing CjeCas9-induced swelling
in differentiated Caco-2 cells at 48 hpi. Transwell sections were fixed and stained with HE (Hematoxylin
and Eosin). Images were taken by phase contrast microscope; scale bars represent 100 µm.
3.2. CjeCas9 Modulates Transcriptomes of Caco-2 Cells during the Early Stages of Infection
To gain insight into the molecular basis behind Caco-2-induced cell damage by CjeCas9-producing
C. jejuni [14], we analyzed the Caco-2 transcriptome at five rationally chosen infection time points
obtained after infection. The raw data are publicly available at NCBI Gene Expression Omnibus (GEO),
accession series GSE89661. Extensive tables including GO enrichment and other analysis results can be
requested from the authors; the most relevant results are summarized here.
To get a first impression of significantly altered gene expression across all transcriptome samples,
non-parametric Kruskal–Wallis and Rank Products (RP) tests [39] were used. The heatmap output
of these tests showed that Caco-2 genes involved in basal and DNA metabolism and cell cycle were
consistently differentially regulated across the arrays in response to bacterial infection, with a clear
distinction in earlier and later infection time points and between WT and its isogenic ∆cas9 mutant
(Figure S1). These results hint at which major processes had been altered in Caco-2 cells during the
first four hours when challenged with WT or its isogenic ∆cas9 mutant but are not sensitive enough to
identify which pathways had been differentially regulated across time.
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3.3. Challenges with WT C. jejuni Strains Alter Gene Expression Profiles of Caco-2 Cells over Time and Are
Associated with Cell Damage
To identify Caco-2 genes with differential expression profiles across all five time points following
challenge by WT or isogenic cas9 deletion mutant strain, time series analysis using Short Time
Series Expression Miner (STEM) software (see the methods section) was used to obtain significantly
differentially expressed, time-resolved Caco-2 gene expression profiles. STEM analysis clusters genes
based on similar gene expression across the (five) time points by comparing expression profiles to
pre-modelled trends (“Profiles”) (for example, cluster genes all being consistently downregulated
across the five time points as in Profile 8 below), and by calculating GO enrichment for each gene cluster.
Three STEM profiles were significantly enriched for specific Gene Ontology (GO) terms after infection
by WT (Figure 2a and Table S1). Profile 8 included genes that had been consistently downregulated
during infection of Caco-2 cells with WT. Profile 8 genes were enriched for GO terms representing
DNA packaging, nucleosome assembly and organization, and DNA binding and gene expression,
suggesting that these processes had been suppressed during infection by WT. Profile 39 included
genes that had been consistently upregulated during WT infection of Caco-2 cells. Profile 39 genes
were enriched for GO terms representing response to wounding, hypoxia, negative regulation of cell
adhesion and cell migration, suggesting that these processes had been induced during infection by WT
C. jejuni. Profile 16 included genes that had been induced during earlier time points and downregulated
at later time points during WT infection. Profile 16 genes were enriched for GO terms representing
kinase activity, cell cycle and cell proliferation, suggesting that the regulation and suppression of the
Caco-2 cell cycle had been modulated via kinase activity. STEM analysis of Caco-2 cells challenged with
the isogenic ∆cas9 mutant yielded three profiles of co-expressed human genes that were enriched for
specific GO terms (Figure 2b and Table S1). Profile 35 included genes that had been downregulated at
earlier time points upon which their expression increased to “t = 0” at later time points. Profile 35 genes
were enriched for GO terms representing DNA packaging, nucleosome assembly and organization and
DNA binding. Profile 24 and Profile 34 included genes that were upregulated at earlier time points
upon which their expression decreased to “t = 0” at later time points. Profile 24 and Profile 34 genes
were enriched for GO terms representing epithelial cell differentiation, adhesion, proliferation and
development, apoptosis and protein metabolic processes including phosphorylation.
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Figure 2. CjeCas9 induces cellular damage by modulating gene expression in Caco-2 cells. (a) The
Table S2 cell transcriptomes after infection with the wild-type CjeCas9-producing C. jejuni strain (WT)
could be clustered in three profiles of genes that were (i) significantly differentially expressed across
time and that (ii) were enriched for specific Gene Ontology (GO) terms (p-values: Profile 8 = 4.7−100,
Profile 39 = 3.6−60 and Profile 16 = 2.6−14). The line graphs show the trend of gene expression; individual
lines represent individual genes. (b) Time-resolved Caco-2 cell transcriptomes after infection challenge
with the isogenic ∆cas9 mutant could be clustered in three profiles of genes that were significantly
differentially expressed across time and enriched for specific GO terms (p-values: Profile 35 = 5.4−151,
Profile 24 = 3.6−18 and Profile 34 = 3.5−19).
3.4. Challenging Caco-2 Cells with a Wild-Type CjeCas9-Producing C. jejuni Strain is Associated with the
Induction of Cell Death and Pro-Inflammatory Signaling Pathways
Based on our earlier work [14], it was of interest to us to identify candidate regulators of
the cell death and pro-inflammatory pathways that were continuously induced by the wild-type
CjeCas9-producing C. jejuni strain. Interestingly, one set of 198 Caco-2 genes was regulated across
time by both WT and its isogenic ∆cas9 mutant (Figure 3a and Table S2). These genes were enriched
for GO terms associated with DNA metabolism, gene expression, cell fate and cell cycle regulation.
Cytoscape network analysis (see the methods section) revealed that the proteins encoded by these
198 genes formed a network that included the cell cycle and immune response regulators JUN
(jun proto-oncogene), FOS (Finkel-Biskis-Jinkins osteosarcoma) and p53 (encoded by the gene TP53) as
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central nodes (Figure 3b). p53, a major stress protein, co-occurred in the network with the GADD45B
protein, that is encoded by the growth arrest and DNA-damage-inducible-alpha gene that is induced
by DNA-damaging agents. This was of interest, since two non-parametric tests showed that genes
involved in DNA and chromatin metabolism had been significantly differentially expressed across all
the individual Caco-2 transcriptome of group 1 and 2 (Figure S1). We therefore further explored the
198-gene set using global gene ontology and functional annotations and pathway mapping using the
online tool DAVID [40].
Figure 3. 198 genes are shared between time-resolved transcriptomes of Caco-2 cells challenged by
wild-type CjeCas9-producing C. jejuni strain (WT) or its isogenic ∆cas9 mutant (a) STEM analysis of
Caco-2 cells transcriptomes infected by WT and its isogenic ∆cas9 mutant yielded a set of 198 genes that
were significantly modulated upon infection by either strain. (b) Cytoscape network analysis (see the
methods section) revealed that the proteins encoded by these genes formed a network including the
cell cycle regulators JUN, FOS and p53 (encoded by the gene TP53) as central nodes.
The genes included in the 198-gene set were enriched in pathways regulating apoptosis
(PANTHER), MAPK (Mitogen-activated protein kinase) signaling (KEGG), IL-6 signaling, hypoxia and
ATM signaling via p53 (DNA damage) pathways (BioCarta); pathway databases in parentheses are
included in DAVID (data not shown). This was of interest since C. jejuni drives IL-6 secretion [41],
MAPK and hypoxia signaling and apoptosis, corroborating DAVID functional predictions for the
198-gene set. Furthermore, about half of the significantly expressed genes found in the non-parametric
tests across all samples were involved in DNA and chromatin metabolism (Figure S1).
The network analysis suggested that JUN, FOS and p53 might be central regulators in the Caco-2
cells when challenged by C. jejuni, specifically by CjeCas9-producing C. jejuni. This was of interest to us
since our previous work suggested that continuous exposure to CjeCas9 is followed by cell death [14].
To investigate the notion that infection by Cas9-producing C. jejuni induces cellular stress via p53 after
four hours, but not during infection by Cas9-non-producing C. jejuni, gene expression was compared
for Caco-2 cells challenged by WT or its isogenic ∆cas9 mutant via the limma t-test (see the methods
section). Caco-2 genes that were significantly differentially expressed at four hours post-infection were
used as input in Ingenuity Pathway Analysis (IPA), which revealed that the WT isolate was significantly
able to induce pathways in Caco-2 cells that are involved in stress responses including DNA damage
(Figure 4 and Table S3), thus in line with our earlier findings [14]. However, these pathways were
not induced during infection challenges of Caco-2 cells by the isogenic ∆cas9 mutant, showing that
loss of Cas9 results in the inability of C. jejuni to induce stress- and DNA damage-signaling pathways
in Caco-2 cells, whereas the corresponding WT strain can do so (Figure 4 and Table S3). Moreover,
exploration of significantly modulated pathways after the infection of Caco-2 cells by WT showed that,
together with p53, NF-κB signaling was induced including the pathway genes TNFR, A20, caspase-8,
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p65(RelA)NF-κB, and CPB/p300, which modulate cell death and pro-inflammatory signaling (Figures
S2 and S3). In contrast, the p53 and NF-κB signaling pathway in Caco-2 cells were not significantly
modulated at four hours post-infection by the isogenic ∆cas9 mutant (Figures S2 and S3; Table S3).
Figure 4. Cellular pathways significantly modulated, induced or repressed in Caco-2 cells at early
time points of infection by WT or its isogenic ∆cas9 mutant. Pathway analysis was carried out using
Ingenuity Pathway Analysis (IPA). Infection by wild-type C. jejuni leads to a significant modulation
of the p53 and JAK-STAT pathways and an induction of DNA-damage response ATM signaling and
Nucleotide-Excision Repair (NER) pathways (red boxes). These stress-associated pathways were not
significantly modulated during infection by the isogenic ∆cas9 mutant (lower graph). In these graphs,
the horizontal yellow line indicated as “Threshold” represents –log (p-value = 0.05); bars higher than
that line represent significantly modulated pathways and processes.
4. Discussion
The enteric zoonotic human pathogen C. jejuni may translocate across intestinal epithelial
cells [14,15,21]. Depending on a strain’s genotype and production of virulence factors, this process
may be associated with cell death, but characterization of toxins has been challenging [5,7]. In our
previous work, we found that, during infection, pathogenic C. jejuni bacteria secrete CjeCas9 via
outer membrane vesicles in the cytoplasm of human cells. After release into the cytoplasm, a native
nuclear localization signal mediates entry of CjeCas9 into the nucleus, where it targets the DNA [14].
The observed swelling of the Caco-2 cells might therefore be a direct effect of the severity of DNA
damage induced by CjeCas9 in the nucleus, affecting homeostasis of the infected cell, more specifically,
homeostasis of ions and water in the cytosol.
Earlier, we have shown that the CjeCas9 nuclease plays a key role in the C. jejuni infection
process [11,12,21], and that CjeCas9 causes severe damage to the human genome in the presence of
metal ions magnesium and manganese [14,21]. Metal ions used by this endonuclease are enriched in
the jejunum, the preferred site of infection in the human intestine by C. jejuni [42–45]. In the current
work, we extended our findings by revealing which human pathways and processes are modulated
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by CjeCas9 in intestinal epithelial cells. We used polarized Caco-2 cell monolayers since when
these epithelial cells are grown as confluent monolayers on micro-porous membranes, they produce
the typical microvilli and a well-defined brush borders that are characteristic for human intestinal
epithelia [46]. We found that the Caco-2 cell response pathways modulated by a CjeCas9-producing
strain include DNA damage, cell death and pro-inflammatory pathways. Our findings are in line with
the DNA damaging and cell death pathology that is specifically observed during the C. jejuni infection
process [14]. The pro-inflammatory pathways modulated by this bacterium might be relevant in
chronic inflammation of the human intestine, one of the post-infectious complications associated with
C. jejuni infections [47]. In fact, C. jejuni-induced tissue damage is a well-known pathogenic feature
demonstrated in biopsies obtained from the intestine of infected patients and in in vitro assays [48,49]
including the swelling of the intestinal epithelial barrier that we also observed in the present work—a
finding reproducible with other WT strains and their isogenic ∆cas9 mutants (results not shown).
Our present and earlier work has shown the contribution of CjeCas9 to this C. jejuni pathology [14,21],
supporting the notion that CjeCas9 functions as a virulence factor.
In previous work, we demonstrated that, six hours post-infection, infected cells exposed to CjeCas9
accumulated p53-binding protein 1 (53BP1) and the phosphorylated histone H2A variant X (γ-H2AX)
into their nuclei [14]. 53BP1 and γ-H2AX both play key roles in the DNA damage response [14] and
interact with p53 and the corresponding signaling pathway that regulates cell cycle, DNA repair,
genome stability and programmed cell death [50–53]. Modulation of the p53 signaling pathway by
Cas9 nucleases may be a more general feature. For example, the Cas9 protein of the bacterial pathogen
Streptococcus pyogenes, SpyCas9, activates the p53 pathway in a wide variety of human cell lines [54–56].
Another host factor commonly associated with C. jejuni infection is NF-κB, which regulates cell
survival genes together with genes involved in the inflammatory response [57,58] and the DNA damage
response [59,60]. NF-κB activation by C. jejuni is reported to occur independently of TLR-2, TLR-4,
Nod1 and Nod2 receptors and suggests a novel mechanism [58]. In gnotobiotic IL-10−/−; NF-κB(EGFP)
mice, NF-κB induction in lamina propria mononuclear cells was associated with ulcerating colonic
inflammation and bloody diarrhea [61]. Our study now shows that the CjeCas9 protein contributes to
NF-κB activation during successful C. jejuni infections.
During the first two-three hours of infection by WT or its isogenic ∆cas9 mutant similar
cell fate-associated genes are modulated in Caco-2 cells. However, the continuous induction of
cell-death-promoting genes occurred only in Caco-2 cells during infection by wild-type CjeCas9
producing C. jejuni, whereas, during infection with the isogenic ∆cas9 mutant, the expression of
cell-death-promoting genes normalized after 2–3 h to levels measured for mock-challenged Caco-2 cells.
Our work thus suggests that CjeCas9 is a key modulator of the DNA damage and cell death response
pathways that are induced upon infection of human intestinal cells by C. jejuni [14]. In conclusion,
this work corroborates our previous finding that CjeCas9 is cytotoxic and highlights, at the RNA level,
the basal cellular pathways that are modulated in Caco-2 cells when exposed to CjeCas9.
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